Education
About Us
Working with TipRanks
Follow Us
Cogstate Ltd (AU:CGS)
ASX:CGS
CGS Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.80 - AU$1.44
Previous CloseN/A
Volume30.50K
Average Volume (3M)149.68K
Market Cap
$220.52M
Enterprise ValueAU$148.93M
Total Cash (Recent Filing)AU$4.26M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)19.9
Beta-0.05
Next Earnings
Aug 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding170,283,260
10 Day Avg. Volume129,157
30 Day Avg. Volume149,684
Financial Highlights & Ratios
PEG Ratio0.56
Price to Book (P/B)N/A
Price to Sales (P/S)3.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.46Price Target Upside11.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
Cogstate Ltd News
PremiumCompany Announcements
Cogstate Ltd Updates on Ongoing Buy-Back Program
PremiumCompany Announcements
Cogstate Ltd Updates on Share Buy-Back Program
PremiumCompany Announcements
Cogstate Ltd Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Cogstate Ltd Updates on Market Buy-Back Progress
PremiumCompany Announcements
Cogstate Ltd Updates on Share Buy-Back Progress
PremiumCompany Announcements
Cogstate Ltd Updates on Share Buy-Back Program
PremiumCompany Announcements
Cogstate Ltd Updates on Ongoing Buy-Back Program
PremiumCompany Announcements
Cogstate Ltd Updates on Securities Buy-Back Program---
Options Prices
Currently, No data available
---
Ownership Overview
17.12% Insiders
0.42%
Mutual Funds
<0.01% Other Institutional Investors
82.45% Public Companies and
Individual Investors
CGS FAQ
What was Cogstate Ltd’s price range in the past 12 months?
Cogstate Ltd lowest share price was AU$0.80 and its highest was AU$1.44 in the past 12 months.
What is Cogstate Ltd’s market cap?
Cogstate Ltd’s market cap is $220.52M.
When is Cogstate Ltd’s upcoming earnings report date?
Cogstate Ltd’s upcoming earnings report date is Aug 26, 2025 which is in 125 days.
How were Cogstate Ltd’s earnings last quarter?
Cogstate Ltd released its earnings results on Feb 19, 2025. The company reported AU$0.036 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.036.
Is Cogstate Ltd overvalued?
According to Wall Street analysts Cogstate Ltd’s price is currently Undervalued.
Does Cogstate Ltd pay dividends?
Cogstate Ltd does not currently pay dividends.
What is Cogstate Ltd’s EPS estimate?
Cogstate Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cogstate Ltd have?
Cogstate Ltd has 170,283,260 shares outstanding.
What happened to Cogstate Ltd’s price movement after its last earnings report?
Cogstate Ltd reported an EPS of AU$0.036 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.855%.
Which hedge fund is a major shareholder of Cogstate Ltd?
Currently, no hedge funds are holding shares in AU:CGS
---
Cogstate Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.46 (11.98% Upside)
$1.46 (11.98% Upside)
Blogger Sentiment
Bullish
AU:CGS Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.34%
12-Months-Change
Fundamentals
Return on Equity
17.87%
Trailing 12-Months
Asset Growth
16.22%
Trailing 12-Months
Company Description
Cogstate Ltd
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
---
CGS Company Deck
---
CGS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, especially in the clinical trials segment, and strong profit before tax. The successful partnership with Medidata also bodes well for future opportunities. However, the decline in contracted future revenue and healthcare revenue, as well as a reduction in workforce, present some challenges. Overall, the positive aspects, particularly the record revenue and profitable growth, outweigh the negatives.Read More>---
CGS Stock 12 Month Forecast
Average Price Target
AU$1.46
▲(11.98% Upside)
Technical Analysis
CardieX Limited
―
Resonance Health Ltd
―
Race Oncology Ltd.
―
Petratherm Ltd
―
IPH Ltd.
―
Best Analysts Covering CGS
1 Year
1 Year Success Rate
4/12 ratings generated profit
1 Year Average Return
-11.38%
reiterated a buy rating 3 months ago
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -11.38% per trade.
---